Phase 2 N=24 Single Dose Study of Phentolamine Mesylate Eye Drops in Patients With Severe Night Vision Disturbances
Decrease in Night Vision · Disturbance; Vision, Loss
Primary: Contrast Sensitivity — 0.6; 0.8; 0.9; 0.7 Patches
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=16 Jowl Improvement With Injectable Fillers
Jowls
Primary: Blinded Physician Jawline Rating Scale (JRS) Assessment on Scale of 0 to 4 at Baseline Versus 4 Weeks After Last Injection. — 2.214; 2.071; 1.857; 1.857 score on a scale…
Phase 4 N=304 A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India
Type 2 Diabetes Mellitus
Primary: Number or Participants With Hypoglycemic Events — 10 participants
Phase 2 N=36 Perioperative Chemo and Pembrolizumab in Gastric Cancer
Gastric Cancer · Adenocarcinoma of the Gastroesophageal Junction
Primary: Pathologic Complete Response (pCR) Rate — 7 Participants
N/A N=52 Application of Carbon Dioxide for Identifying the Intersegmental Plane in Thoracoscopic Segmentectomy
Lung Cancer · Pulmonary Nodule, Solitary · Segmentectomy
Primary: The Intersegmental Border Appearance Time During the Surgery. — 748.74; 157.11 seconds
N/A N=119 Myocardial Injury and Quality of Life After COVID-19
COVID-19 · Myocardial Injury · Myocarditis Post Infection
Primary: Percentage of Patients (%) Recovered From COVID-19 With a Decrease in the Global Contractility of the Left and Right Ventricles. — 19; 39; 48 Participants
Early Phase 1 N=5 Procalcitonin to Reduce Antibiotic Use in Pediatric Pneumonia
Pneumonia · Pediatric Respiratory Diseases · Antibiotic Use
Primary: Total Pilot Trial Enrollment — 0; 1 Participants
N/A N=1,200 Happy Mother-Healthy Baby: An Anxiety-focused Early Prenatal Intervention
Postpartum Depression · Small for Gestational Age at Delivery · Preterm Birth
Primary: Number of Participants With Combined Common Mental Disorders (CMDs, i.e. Anxiety and Depression). — 57; 178 Participants
Phase 2 N=61 A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia
Cervical Dystonia
Primary: Number of Participants With Treatment-Related Serious Adverse Events — 0; 0; 0; 0 Participants
Phase 2 N=81 PRevention Using EPA Against coloREctal Cancer
Colorectal Adenoma · Colorectal Cancer · Endoscopic Surgery
Primary: Change in the Marine Omega-3 Polyunsaturated Fatty Acid (MO3PUFA) Composition in Colorectal Tissues as a Result of the AMR101 Treatment. — 0.54; 2.95 percentage of total…
Phase 2 N=62 Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer
Multiple Myeloma · Hodgkin Lymphoma · Non-Hodgkin Lymphoma
Primary: Number of Days Post HDT-AHCT Requiring Transfusions or Grade 4 CTCAE Thrombocytopenia — 6 days
N/A N=750 mHealth Messaging to Motivate Quitline Use Quitting
Tobacco Use Cessation
Primary: Participant Tobacco Cessation Rate (Quit Rate) at 6 Months — .50; .52 proportion of participants
N/A N=194 Randomized Controlled Clinical Trial of Weight Loss Programs in Obese Persons
Obesity
Primary: Change in Weight From Baseline to 18 Months — -5.0; -3.2 kg
Phase 2 N=48 Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates
Pancreatic Cancer · Pancreatic Adenocarcinoma · Pancreas Ductal Adenocarcinoma
Primary: R0 Resection Rates in Each Cohort as Measured by Macroscopically Complete Tumor Removal With Negative Microscopic Surgical Margins — 9; 9 participants with resectable PDAC
N/A N=45 Using Ultrasound Elastography to Predict Development of SOS
Sinusoidal Obstruction Syndrome · Complications of Bone Marrow Transplant
Primary: Sensitivity and Specificity of US for VOD/SOS — 80; 93 percentage of participants